Do glutathione levels decline in aging human brain?
- PMID: 26845616
- DOI: 10.1016/j.freeradbiomed.2016.01.029
Do glutathione levels decline in aging human brain?
Abstract
For the past 60 years a major theory of "aging" is that age-related damage is largely caused by excessive uncompensated oxidative stress. The ubiquitous tripeptide glutathione is a major antioxidant defense mechanism against reactive free radicals and has also served as a marker of changes in oxidative stress. Some (albeit conflicting) animal data suggest a loss of glutathione in brain senescence, which might compromise the ability of the aging brain to meet the demands of oxidative stress. Our objective was to establish whether advancing age is associated with glutathione deficiency in human brain. We measured reduced glutathione (GSH) levels in multiple regions of autopsied brain of normal subjects (n=74) aged one day to 99 years. Brain GSH levels during the infancy/teenage years were generally similar to those in the oldest examined adult group (76-99 years). During adulthood (23-99 years) GSH levels remained either stable (occipital cortex) or increased (caudate nucleus, frontal and cerebellar cortices). To the extent that GSH levels represent glutathione antioxidant capacity, our postmortem data suggest that human brain aging is not associated with declining glutathione status. We suggest that aged healthy human brains can maintain antioxidant capacity related to glutathione and that an age-related increase in GSH levels in some brain regions might possibly be a compensatory response to increased oxidative stress. Since our findings, although suggestive, suffer from the generic limitations of all postmortem brain studies, we also suggest the need for "replication" investigations employing the new (1)H MRS imaging procedures in living human brain.
Keywords: Aging; Glutathione; Human brain; Oxidative stress; Postmortem.
Copyright © 2016 Elsevier Inc. All rights reserved.
Similar articles
-
Normal glutathione levels in autopsied brain of chronic users of heroin and of cocaine.Drug Alcohol Depend. 2018 Sep 1;190:20-28. doi: 10.1016/j.drugalcdep.2018.05.021. Epub 2018 Jun 23. Drug Alcohol Depend. 2018. PMID: 29960919 Free PMC article.
-
Brain antioxidant systems in human methamphetamine users.J Neurochem. 2004 Jun;89(6):1396-408. doi: 10.1111/j.1471-4159.2004.02434.x. J Neurochem. 2004. PMID: 15189342
-
Glutathione metabolism is modulated by postmortem interval, gender difference and agonal state in postmortem human brains.Neurochem Int. 2011 Dec;59(7):1029-42. doi: 10.1016/j.neuint.2011.08.024. Epub 2011 Sep 14. Neurochem Int. 2011. PMID: 21945455
-
Glutathione in multiple sclerosis: more than just an antioxidant?Mult Scler. 2014 Oct;20(11):1425-31. doi: 10.1177/1352458514533400. Epub 2014 May 19. Mult Scler. 2014. PMID: 24842957 Review.
-
Nutritional intervention in brain aging: reducing the effects of inflammation and oxidative stress.Subcell Biochem. 2007;42:299-318. Subcell Biochem. 2007. PMID: 17612057 Review.
Cited by
-
Molecular Mechanisms and Genetics of Oxidative Stress in Alzheimer's Disease.J Alzheimers Dis. 2019;72(4):981-1017. doi: 10.3233/JAD-190863. J Alzheimers Dis. 2019. PMID: 31744008 Free PMC article. Review.
-
Is There a Glutathione Centered Redox Dysregulation Subtype of Schizophrenia?Antioxidants (Basel). 2021 Oct 27;10(11):1703. doi: 10.3390/antiox10111703. Antioxidants (Basel). 2021. PMID: 34829575 Free PMC article. Review.
-
Concentration, distribution, and influence of aging on the 18 kDa translocator protein in human brain: Implications for brain imaging studies.J Cereb Blood Flow Metab. 2020 May;40(5):1061-1076. doi: 10.1177/0271678X19858003. Epub 2019 Jun 20. J Cereb Blood Flow Metab. 2020. PMID: 31220997 Free PMC article.
-
Glutathione, the Major Redox Regulator, in the Prefrontal Cortex of Individuals at Clinical High Risk for Psychosis.Int J Neuropsychopharmacol. 2018 Apr 1;21(4):311-318. doi: 10.1093/ijnp/pyx094. Int J Neuropsychopharmacol. 2018. PMID: 29618014 Free PMC article.
-
MRS demonstrates elevated brain glutathione in vascular mild cognitive impairment compared to cognitively normal coronary artery disease controls.Alzheimers Dement. 2025 May;21(5):e70230. doi: 10.1002/alz.70230. Alzheimers Dement. 2025. PMID: 40371694 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous